2,055
Participants
Start Date
January 15, 2018
Primary Completion Date
November 11, 2021
Study Completion Date
November 30, 2021
Rivaroxaban 2.5 mg
One 2.5 mg rivaroxaban tablet twice daily until hospital discharge or 12 hours before revascularization therapy for a maximum of 8 days.
Rivaroxaban 5 mg
One 5 mg rivaroxaban tablet twice daily until hospital discharge or 12 hours before revascularization therapy for a maximum of 8 days.
Enoxaparin
Enoxaparin 1mg/kg twice daily SC until hospital discharge or 12 hours before revascularization therapy for a maximum of 8 days.
Changsha Central Hospital, Changsha
Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha
The Forth Hospital of Changsha, Changsha
The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha
The Second Xiangya Hospital of Central South University, Changsha
The First Hospital of Changsha, Changsha
The Third Xiangya Hospital of Central South University, Changsha
The Third Hospital of Changsha, Changsha
Xiangxiang People's Hospital, Xianxiang
Xiangtan Central Hospital, Xiangtan
Zhuzhou Central Hospital, Zhuzhou
Yiyang Central Hospital, Yiyang
The First People's Hospital of Yueyang, Yueyang
The First People's Hospital of Changde City, Changde
The First Affiliated Hospital of Jishou University, Jishou
The First People's Hospital of Loudi, Loudi
The First Affiliated Hospital of Hunan University of Medicine, Huaihua
The First People's Hospital of Huaihua, Huaihua
The First Affiliated Hospital of University of South China, Hengyang
The Second Affiliated Hospital of University of South China, Hengyang
The Central Hospital of Shaoyang, Shaoyang
The First People's Hospital of Chenzhou, Chenzhou
Yongzhou First People's Hospital, Yongzhou
The Second People's Hospital of Hunan Province, Changsha
Second Xiangya Hospital of Central South University
OTHER